Heleen Marynissen

Co-creation with research participants to inform the design of electronic informed consent

I. Huys, P. Borry, E. De Sutter, 2022, Digital health.

First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan

A. van Hecken, L. Buntinx, M. Depré, 2022, Clinical and translational science.

Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review

K. Allegaert, J. D. de Hoon, Heleen Marynissen, 2020, BMJ paediatrics open.

Doppler ultrasound to assess the pharmacodynamic effects of splanchnic vasoactive compounds

D. Bielen, J. D. de Hoon, Heleen Marynissen, 2021, British journal of clinical pharmacology.

Does etodolac affect TRPA1 functionality in vivo in human?

J. D. de Hoon, Dorien Bamps, Heleen Marynissen, 2023, Journal of Basic and Clinical Physiology and Pharmacology.

Glucocorticoids Do Not Affect the Vascular Component of TRP-Mediated Neurogenic Skin Inflammation

Heleen Marynissen, Jan de Hoon, 2024, Journal of inflammation research.